Safety, pharmacokinetics and pharmacodynamics of SYN023 alone or in combination with a rabies vaccine: An open, parallel, single dose, phase 1 bridging study in healthy Chinese subjects-Reference-Cited by-同舟云学术

Safety, pharmacokinetics and pharmacodynamics of SYN023 alone or in combination with a rabies vaccine: An open, parallel, single dose, phase 1 bridging study in healthy Chinese subjects

Published:2020-12 Issue: Volume:184 Page:104956
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Ding Yanhua,Wu Min,Zhang Hong,Zhu Xiaoxue,Hu Yue,Li Xiaojiao,Liu Jingrui,Tsao Eric,Liu Ming,Li Cuiyun

Funder

National Major Scientific and Technological Special Project

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference22 articles.

1. Rabies pathogenesis and immunology;Banyard;Rev. Sci. Tech.,2018

2. Passive immunity in the prevention of rabies;Both;Lancet Infect. Dis.,2012

3. SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies;Chao;PLoS Neglected Trop. Dis.,2017

4. A comprehensive review of the pharmacokinetics of approved therapeutic monoclonal antibodies in Japan: are Japanese phase I studies still needed?;Chiba;J. Clin. Pharmacol.,2014

5. Receptors for the Fc portion of immunoglobulin G (Fc gamma R) on human monocytes and macrophages;Comber;Prog. Clin. Biol. Res.,1989

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity of rabies virus G mRNA formulated with lipid nanoparticles and nucleic acid immunostimulators in mice;Vaccine;2023-11

2. Lyssaviruses and Rabies Vaccines;Plotkin's Vaccines;2023

3. Neutralizing antibody activity, safety and immunogenicity of human anti-rabies virus monoclonal antibody (Ormutivimab) in Chinese healthy adults: A phase Ⅱb randomized, double-blind, parallel-controlled study;Vaccine;2022-10

4. Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy;Current Opinion in Virology;2022-04

5. Efficacy of ormutivimab, a novel recombinant human anti-rabies monoclonal antibody, in post-exposure prophylaxis animal models;Travel Medicine and Infectious Disease;2022-03